These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 37105794)
1. Genomics of myelodysplastic/myeloproliferative neoplasm. Patwardhan PP; Aarabi M; Aggarwal N Semin Diagn Pathol; 2023 May; 40(3):195-201. PubMed ID: 37105794 [TBL] [Abstract][Full Text] [Related]
2. Advances in myelodysplastic/myeloproliferative neoplasms. Prakash S; Arber DA; Bueso-Ramos C; Hasserjian RP; Orazi A Virchows Arch; 2023 Jan; 482(1):69-83. PubMed ID: 36469102 [TBL] [Abstract][Full Text] [Related]
3. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
4. Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms. Li Y; Beck RC; Moore EM Am J Clin Pathol; 2021 Sep; 156(4):634-643. PubMed ID: 33877292 [TBL] [Abstract][Full Text] [Related]
5. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. Fei F; Jariwala A; Pullarkat S; Loo E; Liu Y; Tizro P; Ali H; Otoukesh S; Amanam I; Artz A; Ally F; Telatar M; Nakamura R; Marcucci G; Afkhami M Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337700 [TBL] [Abstract][Full Text] [Related]
6. Progression in Myeloid Neoplasms: Beyond the Myeloblast. Faria C; Tzankov A Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015 [TBL] [Abstract][Full Text] [Related]
7. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm. Ibrar W; Zhang W; Cox JL; Cushman-Vokoun A; Fu K; Greiner TC; Yuan J Int J Lab Hematol; 2021 Dec; 43(6):1501-1509. PubMed ID: 34270867 [TBL] [Abstract][Full Text] [Related]
8. Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates. Geyer JT; Orazi A Int J Lab Hematol; 2016 May; 38 Suppl 1():12-9. PubMed ID: 27161873 [TBL] [Abstract][Full Text] [Related]
9. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T. Talati C; Padron E Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113 [TBL] [Abstract][Full Text] [Related]
11. The implications of revised WHO classification (2008) of chronic myeloid neoplasms. Găman M; Vlădăreanu AM; Radesi S Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249 [TBL] [Abstract][Full Text] [Related]
12. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes. Tiu RV; Sekeres MA Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705 [TBL] [Abstract][Full Text] [Related]
13. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management. Patnaik MM; Tefferi A Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682 [TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review. Fontana D; Elli EM; Pagni F; Piazza R Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370785 [TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes. Thota S; Gerds AT Leuk Lymphoma; 2018 Apr; 59(4):803-812. PubMed ID: 28771058 [TBL] [Abstract][Full Text] [Related]
16. Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2 Todisco G; Creignou M; Gallì A; Guglielmelli P; Rumi E; Roncador M; Rizzo E; Nannya Y; Pietra D; Elena C; Bono E; Molteni E; Rosti V; Catricalá S; Sarchi M; Dimitriou M; Ungerstedt J; Vannucchi AM; Hellström-Lindberg E; Ogawa S; Cazzola M; Malcovati L Leukemia; 2021 Aug; 35(8):2371-2381. PubMed ID: 33349666 [TBL] [Abstract][Full Text] [Related]